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Group A carbohydrate (GAC) is a bacterial peptidoglycan-
anchored surface rhamnose polysaccharide (RhaPS) that is
essential for growth of Streptococcus pyogenes and contributes
to its ability to infect the human host. In this study, usingmolec-
ular and synthetic biology approaches, biochemistry, radiola-
beling techniques, and NMR andMS analyses, we examined the
role of GacB, encoded in the S. pyogenes GAC gene cluster, in
the GAC biosynthesis pathway. We demonstrate that GacB is
the first characterized -D-GlcNAc--1,4-L-rhamnosyltransferase
that synthesizes the committed step in the biosynthesis of the
GAC virulence determinant. Importantly, the substitution of
S. pyogenes gacB with the homologous gene from Streptococcus
agalactiae (Group B Streptococcus), Streptococcus equi subsp.
zooepidemicus (GroupCStreptococcus),Streptococcusdysgalac-
tiae subsp. equisimilis (Group G Streptococcus), or Streptococ-
cus mutans complemented the GAC biosynthesis pathway.
These results, combined with those from extensive in silico
studies, reveal a common phylogenetic origin of the genes
required for this priming step in>40 pathogenic species of the
Streptococcus genus, including members from the Lancefield
Groups B, C, D, E, G, and H. Importantly, this priming step
appears to be unique to streptococcal ABC transporter–depen-
dent RhaPS biosynthesis, whereas the Wzx/Wzy-dependent
streptococcal capsular polysaccharide pathways instead require
an-D-Glc--1,4-L-rhamnosyltransferase. The insights into the
RhaPS priming step obtained here open the door to targeting
the early steps of the group carbohydrate biosynthesis pathways
in species of the Streptococcus genus of high clinical and veteri-
nary importance.
Streptococcus pyogenes is a versatile Gram-positive bacte-
rium that infects only humans and is responsible for a remark-
able number of mild to severe illnesses. At least 700 million
individuals are affected each year worldwide by diseases as var-
ied as impetigo, pharyngitis, scarlet fever, necrotizing fasciitis,
meningitis, and toxic shock syndrome, among others (1–4).
Moreover, autoimmune postinfection sequelae with high mor-
tality rates, such as acute rheumatic fever, acute glomerulone-
phritis, or rheumatic heart disease, can affect individuals who
had previously suffered fromGroupA Streptococcus infections,
extending the list of clinical manifestations caused by this
severe pathogen (5, 6).
As suggested by its diverse clinical manifestations, S. pyo-
genes rely on different mechanisms to withstand the host’s
defenses (7–11). These mechanisms are supported by the syn-
thesis of a wide array of virulence factors, among which is the
Group A carbohydrate (GAC),4 a surface polysaccharide that
constitutes between 40 and 60% of the bacterial cell wall (12–
15). GAC is composed of a [33)-Rha(132)-Rha(13] rham-
nose polysaccharide (RhaPS) backbone with a -D-GlcNAc
(133) side chainmodification on every-1,2–linked rhamnose
(Rha) (15–17). Recent structural examinations and composi-
tion analysis of the GAC also suggest the presence of glycerol
phosphate (GroP) (18), an observation that remained unno-
ticed for over 50 years (19, 20). Further, Edgar et al. (18) dem-
onstrated that 25% of GAC side-chain GlcNAcs are deco-
rated with GroP, imparting a negative charge to this polymer
that has implications for S. pyogenes biology and defensemech-
anisms (19, 21). This feature, previously identified in other sur-
face glycans (22, 23), provided new insight into the structural
composition, biosynthesis, and function of GAC.
GAC is proposed to be synthesized by 12 proteins, GacABC-
DEFGHIJKL, encoded in one gene cluster (i.e. MGAS5005_
spy0602–0613) that has been found in all S. pyogenes species
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identified so far (7, 24). Through sequencing of transposon
mutant libraries, Le Breton et al. (10, 25) discovered that eight
of these genes, gacABCDEFG and gacL, are essential for S. pyo-
genes survival. This information supports the observation by
van Sorge et al. (7), who identified via insertional mutagenesis
that the first three genes of the cluster (gacABC) are essential.
The present hypothesis is that the GAC is formed in six con-
secutive steps, depicted in Scheme 1: (i) lipid-linked acceptor
initiation, (ii) [33)-Rha(132)-Rha(13] RhaPS backbone
synthesis, (iii) membrane translocation, (iv) synthesis of side-
chain precursor, (v and vi) post-translocational chainmodifica-
tion steps. This product is linked to peptidoglycan (15). The
cytoplasmic pool of TDP--L-rhamnose (TDP-Rha) necessary
for RhaPS backbone synthesis is supplied by enzymes encoded
in two separate gene clusters rmlABC and gacA/rmlD (24). Step
(i) involves the addition of a Rha residue to a GlcNAc-
PP-undecaprenyl (Und, WT2C8-). Rush et al. proposed that
either GacB or GacC are a rhamnosyltransferase that trans-
fers the first Rha residue onto the 3-OH group of the
GlcNAc-PP-Und (14). The formation of the [33)-Rha(132)
-Rha(13] RhaPS backbone constitutes the elongation step
(ii), presumably achieved at the inner leaflet of the membrane
by the glycosyltransferases (GTs) GacC, GacF, and GacG (14).
However, the precise role of each GTs in the synthesis of the
RhaPS backbone remains unknown. Consistent with this
hypothesis are findings related to the biosynthesis of the Strep-
tococcus mutans serotype C carbohydrate (SCC, previously
referred to as RGP). Shibata et al. (26) reported that the genes
rgpA/sccB, rgpB/sccC, and rgpF/sccG of this dental pathogen
(homologs of gacB, gacC, and gacG, respectively) are required
for the biosynthesis of the RhaPS backbone, although the struc-
tural or mechanistic examination of these enzymes was never
conducted. According to the current gene annotation, the
translocation step (iii) is proposed to be catalyzed by an ATP-
dependent ABC transporter encoded by gacD and gacE (7, 14,
15). Concerning the post-translocational RhaPS modifications
(v, vi), recent insights revealed that GacI synthesizes the sugar
donor precursor GlcNAc-P-Und (iv) and that GacJ forms a
complex with GacI to enhance the catalytic efficiency of
this process (14). The lipid-linked monophosphate sugar
GlcNAc-P-Und is proposed to be flipped across the membrane
by GacK (14, 15). Furthermore, GacL was shown to utilize the
extracellular GlcNAc-P-Und by transferring the GlcNAc onto
theRhaPS backbone, to insert the antigenic-D-GlcNAc (133)
side chain modification on every -1,2-linked rhamnose.
Finally, GacH is a GroP-transferase that decorates the
RhaPS-GlcNAc side chain (18). Enzymes conducting the trans-
fer of GAC to the peptidoglycan as well as its linkage, pre-
sumably through phosphodiester bond (18), remain to be
elucidated.
Often, the production of bacterial cell wall structures deter-
mines the fate of a bacterium in a given environment. Glycopo-
lymers in particular, such as cell wall teichoic acids and capsular
polysaccharides, are involved in growth, cell division, and bac-
terial homeostasis (15, 27–34). In the context of human health,
these glycopolymers have been shown to play a significant role
in biofilm formation, antibiotic resistance, host cell adhesion,
and resistance to the host immune response by, for example,
blocking antibacterial peptides and evading phagocytosis (8, 24,
35–39).
Many species within the Lactobacillales order present a sur-
face RhaPS intertwined with additional components of the
SCHEME 1. Current model for the GAC biosynthesis pathway from S. pyogenes, Group A Streptococcus.
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thick cell wall that is typical of Gram-positive bacteria. These
surface glycans, as with other critical peptidoglycan-anchored
structures, are essential for cell viability and play an essential
role in pathogenesis (7, 9, 15, 24, 36, 40–42). In the Streptococ-
cus genus, in particular in S. pyogenes, S. agalactiae, and
S. mutans, genetic studies conducted on S. pyogenes strains
showed that the absence of rhamnose glycopolymers results in
severe growth defects associated with an altered cell wall and
an increased susceptibility to muralytic enzymes (7, 25, 43,
43–45). Moreover, in vivo studies revealed that RhaPS deple-
tion or its modification reduced the ability of S. pyogenes,
S. agalactiae, and S. mutans to evade the immune system and
attenuated their virulence (7, 25, 46–49).
Based on its essentiality, its role in pathogenesis, and the
current evidence of the importance of RhaPS in bacterial
homeostasis, we are confident that the detailed elucidation
of all steps in the GAC biosynthesis pathway will play a deci-
sive role in the development of antimicrobial drugs and anti-
streptococcal vaccines in the near future (7, 46, 50). Despite
the recent progress, several pressing questions remain unan-
swered regarding the biosynthesis of GAC. For example, the
products of six of the 12 genes that constitute the GAC clus-
ter (gacBCDEFG) have not yet been characterized, including
the essential steps of GAC initiation, RhaPS backbone bio-
synthesis, and GAC translocation.
As a means of attaining more information on the GAC initi-
ation step, we conducted an in-depth examination of the
second enzyme encoded in the GAC gene cluster. Here we
demonstrate that GacB, in disagreement with its preliminary
genetic annotation and currently proposed mechanism of
action (14), is the first rhamnosyltransferase in this pathway
that transfers L-rhamnose from TDP--L-rhamnose onto the
acceptor GlcNAc-PP-Und. GacB thereby forms a -1,4-glyco-
sidic bond between rhamnose and the lipid-linked GlcNAc
through a metal-independent mechanism. Strikingly, our
research on phylogenetically related homologs from other
important human pathogenic streptococci, in particular from
the Lancefield Groups B, C, andG, reveals that the role of GacB
is conserved within the Streptococcus genus, suggesting a com-
mon first committed step for the production of RhaPS from all
Lancefield groups. Thus, the implication of this research is rel-
evant for those seeking to understand the pathogenesis and
potential therapeutic interventions against streptococcal spe-
cies important to human and animal health.
Results and discussion
Protein sequence analysis of the putative
rhamnosyltransferase GacB
The current gene annotation indicates that the second gene
of the GAC cluster encodes a putative -D-GlcNAc--1,2-L-
rhamnosyltransferase, named GacB (7, 15). Recent findings
revealed that GlcNAc-PP-Und is essential for the GAC RhaPS
backbone biosynthesis in S. pyogenes (14), supporting the cur-
rent hypothesis that the addition of rhamnose during the initi-
ation step occurs directly onto this lipid-disphosphate sugar
acceptor (7, 15, 18). The gacB gene product is a 384-amino-
acid-long polypeptide with a theoretical molecular mass of 44
kDa; this is consistent with the size of other known single-reac-
tion GTs (51, 52).
In silico topological predictions conducted with SpOctopus-
and TMHMM-based algorithms (53–55) indicate that GacB
does not contain a signal peptide sequence but possesses a short
hydrophobic region at its N terminus end, suggesting that this
protein is not secreted but is tethered to the cytosolic side of the
membrane (Fig. S1). This prediction is in agreement with the
proposed function catalyzing the reaction onto a lipid-linked
acceptor, as well as with the observed membrane association
during the heterologous protein expression.
The most relevant structural information provided by the
domain architecture analysis is that GacB belongs to the RfaB
superfamily of GTs, a group of nucleotide sugar-dependent
enzymes known to be involved in cell wall biosynthesis (54, 55).
In the absence of any known function, GacB has been prelimi-
narily classified based on its protein sequence into the GT4
family, a group of GTs with diverse biological functions with a
characteristic GT-B type fold. The enzymes composing this
group act through a retaining catalytic mechanism, meaning
that the resulting stereochemistry at the anomeric carbon is
conserved between the sugar donor and the product (56–61).
The sequence analysis revealed that GacB has two
conserved domains, the GT_1_like6 domain covering the
entire primary sequence (residues 1–384) and the domain of
unknown function DUF1972 at the N terminus (residues
1–185). The DUF1972 domain is widely spread among gly-
cosyltransferases (and rhamnosyltransferases) but has no
defined functionality (55).
GacB shares 68% sequence amino acid identity and the same
type of predicted domains as S. mutans SccB (Table 1), which
has been proposed to initiate the biosynthesis of the SCC
in S. mutans, a polysaccharide that also contains a RhaPS
backbone (14, 26, 47, 62). Importantly, SccB also requires
GlcNAc-PP-Und as an acceptor, as the biosynthesis of the sur-
face polysaccharide is abrogated in an E. coli wecA deletion
strain (26, 56). WecA is the enzyme responsible for the
GlcNAc-PP-Und biosynthesis in E. coli. GacO is the functional
homolog of WecA in S. pyogenes, whereas S. mutans and sev-
eral other streptococci contain similar homologs (26, 32, 63).
Based on GacB’s preliminarily annotation as a nucleotide
sugar-dependent rhamnosyltransferase, its genomic location
within the GAC cluster, and its similarity to SccB, we selected
GacB as the most likely candidate catalyzing the first rhamno-
sylation step in theGACbiosynthesis process. According to our
hypothesis, GacB would attach a single rhamnose residue onto
a membrane-bound GlcNAc to form Rha-GlcNAc-PP-Und
through an unknown glycosidic linkage.
GacB is required for the biosynthesis of the GAC RhaPS chain
To further investigate the GacB function and to identify
potential catalytic residues, we used E. coli as a heterologous
expression system to study the GAC RhaPS backbone biosyn-
thesis. Previously, the transformation of E. coli cells with the
S. mutans genes sccA–G was sufficient to produce the SCC
RhaPS backbone, whereas the absence of sccB, encoding the
GacB homolog, abrogated the RhaPS backbone biosynthesis
(26, 64). Inspired by this approach, we constructed two vectors
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carrying the homologous genes from S. pyogenes, gacACDEFG
(gacA–G; gacB) and gacB (Fig. 1A).
The RhaPS chain is presumed to be translocated to the outer
membrane in E. coli, which naturally contains rhamnose
attached to the lipopolysaccharides. Thus, to avoid nonspecific
binding of the anti-GAC antibody, all transformations were
madeusing an rfaS-deficient strain (26). The interruption of the
rfaS gene impedes the attachment of rhamnose to the LPS on
the bacterial outer membrane, rendering a strain that lacks
endogenous rhamnose on its surface (26, 62, 65, 66). The role of
GacB was investigated using a traditional complementation
strategy (Fig. 1).
We investigated the production of RhaPS by gacA–G from
our complementation approach using immunoblots of total cell
lysates (Fig. 1B). If the expression of GacBCDEFG is sufficient
to produce the RhaPS chain, then we should be able to detect
the synthesized RhaPS using a specific anti-GAC antibody. The
results showed that E. coli cells lacking the gacA-G gene cluster
(empty vector) did not produce RhaPS (Fig. 1, lane 2). Likewise,
transformants bearing the gacB or sccB plasmids lost reac-
tivity with the GAC antibody (Fig. 1, lanes 3 and 5). Instead,
co-transformation of sccB  sccB or gacB  gacB restored
the RhaPS production, underlining the essentiality of sccB and
gacB for the biosynthesis of the GAC backbone (Fig. 1, lanes 4
and 6).
To investigate whether GacB and SccB are catalyzing the
same reaction, we tested the ability of GacB to functionally
substitute SccB and vice versa by co-transformingsccB gacB
and gacB  sccB. In all cases, SccB and GacB were inter-
changeable (Fig. S2). GacB’s predicted initiation codon was dif-
ferent from S. mutans SccB, with the latter using TTG instead
of ATG (Fig. S2). The use of TTG as initiation codon has been
identified as a factor that decreases the efficiency of translation
in both E. coli and the nematode Caenorhabditis elegans (67,
68). Therefore, it is conceivable that this is a strategy used by the
cell to limit the expression of the proteins involved in the RhaPS
biosynthesis.
Interestingly, the gacB homolog in Streptococcus gallolyticus
subsp. gallolyticus (ATCC_43143) is annotated as a shortened,
235-amino-acid-long polypeptide that also contains a TTG
codon 153 nucleotides upstream of the annotated GTG start
codon. In light of this discovery, a genetic reannotation of
S. mutans’ sccB and its homolog in S. gallolyticus subsp. gallo-
lyticus would be required, as well as a re-evaluation of these
species’ genome for potentially new or larger gene products
that are initiated by a TTG codon.
We decided to test two versions of SccB: one with a TTG as
the initiation codon and the other one with an ATG. Both ver-
sions rendered an active enzyme that could complement either
sccB and gacB (Fig. S2). Unless stated otherwise, all further
work was conducted using sccB constructs with the native TTG
start codon.
GacB extends a lipid-linked precursor
We investigated whether GacB is a GT that uses
GlcNAc-PP-Und as an acceptor. Through an in vivo experi-
ment, we generated radiolabeled lipid-linked saccharides
(LLSs), which were isolated from the bacterial membrane and
separated via thin-layer chromatography (TLC). Based on the
annotation as a rhamnosyltransferase, radiolabeled TDP--L-
rhamnose would be the preferred sugar donor for GacB. How-
ever, this compound is not commercially available; therefore,
tritiated glucose was chosen as an alternative. Inside the bacte-
rial cell, glucose is used as a substrate to synthesize a wide array
of organic components, including TDP--L-rhamnose (69).
We hypothesized that GacB transfers an activated sugar
from a (radiolabeled) nucleotide sugar donor to a mem-
brane-bound acceptor monosaccharide-PP-Und (e.g. GlcNAc-
PP-Und). Therefore, we expect a lower chromatographic
mobility (Rf) value of the membrane-bound acceptor, com-
pared with the Rf of the monosaccharide lipid-linked acceptor
after running the samples in a TLC plate. As a negative control,
we used E. coli CS2775 (rfaS) transformed with the empty
vector.This transformant showedachromatographic zonecon-
sistent with the generation of monosaccharide-PP-Und (Fig. 2,
Table 1
Sequenceconservation inpercentage forGacBandGacOhomologous
enzymes from 48 species of the Streptococcus genus
Carbohydrate gene clusters containing eitherABCorWzx/Wzy-encoding genes for
carbohydrate translocation and polymerization are marked.
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lane 1). Upon expression of either the gacB or sccB genes, we
observed the accumulation of a radioactive signal thatmigrated
more slowly on theTLCplate, suggesting a highermolecularmass
for these compounds (Fig. 2, lanes 3 and 4). The same Rf shift was
observed for the sccAB-DEFG (sccC) construct (Fig. 2, lane 2),
demonstrating that sccB and gacB can glycosylate a lipid-linked
precursor.Basedon the literature,weassumethat theupper radio-
labeled chromatographic signal corresponds to GlcNAc-PP-Und
and the lower one to Rha-GlcNAc-PP-Und (14, 15).
GacB is a glycosyltransferase transferring rhamnose from
TDP--L-Rha onto GlcNAc-PP-lipid acceptors
The observed band shift suggested that GacB adds a mono-
saccharide to a lipid-linked precursor, most likely GlcNAc-
PP-Und. We investigated this hypothesis using recombinantly
produced and purified GacBWT and amino acid mutants (Fig.
S3). We established an in vitro assay using the predicted nucle-
otide sugar donor, TDP--L-rhamnose, and a synthetic accep-
tor substrate. We tested two of these synthetic substrates
designed to mimic the native lipid-linked acceptor: CH3(CH2)12-
PP-GlcNAc (acceptor 1) and PhO(CH2)11-PP-GlcNAc (acceptor
2) (Fig. 4C). The enzymatic reaction products were purified and
characterized usingMALDI-MS in positive-ionmode.
The MALDI-MS spectra of the enzymatic reaction products
(Fig. 3) confirmed that GacB catalyzes the addition of one
rhamnose residue to both acceptor substrates when incubated
with TDP--L-Rha (Fig. 3, B and E). Acceptor 1 possesses a
molecular mass of 563 Da and is detected at both m/z  608
[M 1H 2Na] andm/z 630 [M 2H 3Na] (Fig. 3A).
GacB-GFP and GacB lacking the GFP tag modified the accep-
tor, resulting in one predominant peak atm/z 776 [M 2H
3Na] (Fig. 3,B andC). In this spectrum,we can also observe an
additional peak of lower intensity at m/z  754 [M  1H 
2Na], corresponding to the modified acceptor 1 coupled with
two Na ions instead of three Na ions. In both cases, the
products are shifted bym/z 146 compared with the unmod-
ified acceptor, which is consistent with the addition of one
rhamnose residue via a glycosidic linkage. The same mass shift
was observed for the second acceptor; the peaks of the unmod-
ified acceptor 2 (Fig. 3D) were detected atm/z 672 [M 1H
2Na] andm/z 694 [M 2H 3Na], whereas the product
peaks emerge atm/z 818 [M 1H 2Na] andm/z 840
[M 2H 3Na] (Fig. 3, E and F). We also tested the ability of
GacB to catalyze the rhamnosylation of GlcNAc--1-P, but the
reaction rendered no detectable product (data not shown), sug-
gesting that theenzymenotonly interactswith theGlcNAc--1-P,
Figure 1. A, complementation strategy and map of S. pyogenes (purple) and S. mutans (red) genes required to produce the RhaPS polyrhamnose backbone.
S. mutans cluster: sccA (Smu0824), sccB (Smu0825), sccC (Smu0826), sccD (Smu0827), sccE (Smu0828), sccF (Smu0829), sccG (Smu0830). S. pyogenes cluster:gacA
(M5005_Spy_0602), gacB (M5005_Spy_0603), gacC (M5005_Spy_0604), gacD (M5005_Spy_0605), gacE (M5005_Spy_0606), gacF (M5005_Spy_0607), gacG
(M5005_Spy_0608). B, bacterial complementation assay in E. coli CS2775 cells. Immunoblot of a Tricine SDS-PAGE with whole-cell samples probed with
anti-Group A carbohydrate antibody.
Figure 2. TLC analysis of radiolabeled LLSs extracted from E. coli cells
containing the empty vector (negative control) or plasmids encoding
S. mutans SccAB-DEFG, S. pyogenesGacB, or S. mutans SccB. Below is the
symbolic representation of the predicted synthesis products (Und-PP). Gray
circle, phosphate; blue square, GlcNAc; green triangle, rhamnose.
EDITORS’ PICK: Conserved Lancefield antigen initiation
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butmight require the second phosphate and the lipid component
to recognize the acceptor substrate.
We further investigatedGacB’s specificity toward the sugar–
nucleotide donor. In particular, we tested whether GacB is
selective for thymidine-based nucleotides and tolerates uri-
dine-based nucleotides, such as UDP-Glc, UDP-GlcNAc, and
UDP-Rha. As shown before, in the presence of TDP--L-Rha,
two products consistent with the incorporation of rhamnose
residue plus either two or three sodium cations were observed
in the spectrum (Fig. S4A). In contrast, no product peaks were
observed with the -D-configured substrates UDP--D-Glc or
UDP--D-GlcNAc (Fig. S4, B and C), whereas residual activity
was detected for UDP--L-Rha (Fig. S4D). These data demon-
strate that GacB does not tolerate -D–configured nucleotide
sugars. Furthermore,GacBhas specificity toward the deoxythy-
midine moiety (TDP-Rha) or requires binding of the thymine
methyl group.
Finally, we assessed metal ion dependence in vitro. Com-
pared with the control reaction (Fig. S5B), we noticed no signif-
icant differences in the rhamnosylation activity of the enzyme
whenGacBwas supplementedwithMgCl2,MnCl2, or EDTA as
a metal chelator (Fig. S5, C–E), indicating that GacB does not
require a divalent metal ion for its activity. These data are in
agreement with the lack of a conserved DXD motif found in
metal-dependent GTs (70, 71).
Together, these data confirmed our previous conclusions
drawn from the LLSs radiolabeled assay (Fig. 2). These results
provide the first in vitro evidence revealing thatGacB is ametal-
independent rhamnosyltransferase that catalyzes the initiation
step in the GAC RhaPS backbone biosynthesis by transferring
Figure 3. In vitro assessment GacB’s function detected via MALDI-MS. Spectra were obtained from the enzymatic reaction sample with the substrate
TDP-Rha and acceptor 1 (CH3(CH2)12-PP-GlcNAc) (A), acceptor 1  GacB-GFP (B), acceptor 1  GacB cleaved (no GFP fusion) (C), acceptor 2
(PhO(CH2)11-PP-GlcNAc) (D), acceptor 2  GacB-GFP (E), acceptor 2  GacB cleaved (no GFP) (F), acceptor 2  GacB-D160N GFP (G), or acceptor 2 
GacB-Y182N-GFP (H).
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single rhamnose toGlcNAc-PP-Und using TDP--L-Rha as the
exclusive activated nucleotide sugar donor.
Investigation of GacB’s catalytic residues
There are no available crystal structures of proteins with a
high degree of identity to GacB. Therefore, we constructed a
GacB structuralmodel based on two enzymes that belong to the
GT4 family of GTs: Bacillus anthracis’ BaBshA (PDB entry
3MBO) (72) and Corynebacterium glutamicum’s MshA (PDB
entry 3C4V) (57). Both proteins have low amino acid sequence
identity compared with GacB, making the identification of
potential catalytic residues to mutate in GacB very challenging.
BaBshA shares only 15% identity in only 64 of 424 amino acids.
MshA is an equally distant “homologous” GT that shares 16%
identical residues in a sequence stretch of only 71 residues of
446. Based on the scarce information provided by the structural
models and the multiple-sequence alignment described in
detail below, we mutated several residues that are highly con-
served in over 40 pathogenic streptococci species (Fig. S7).
Our in vitro E. coli system is the first one that enables the
study of GacB mutant proteins, allowing the identification of
thosemutants that abrogate or reduce the production of RhaPS
backbone. Conducting this in S. pyogenes is not possible, as
gacB is essential (7, 26).We used the information available from
the GT models mentioned above and the sequence alignment
of multiple streptococci to select residues that might be
involved in substrate binding, which tends to be conserved
among GT. Through in situmutagenesis, we constructed nine
recombinant versions of GacB containing the following amino
acid substitutions: D126A, D126N, E222A, E222Q, D160A,
D160N, Y182A, Y182F, and K131R. The latter mutation was
included as a negative control because it is a conserved pre-
dicted surface residue that presumably is not engaged in the
catalytic activity or could inactivate the enzyme otherwise.
Our results show that substitution of Asp-160 with an aspar-
agine (Fig. S6, lane 5) led to a drastic reduction in the produc-
tion of the RhaPS chain, whereas an alanine residue did not
cause such a significant effect. This suggests that the Asp-160
carboxyl group might be required for catalysis, which poten-
tially can be replaced in the alaninemutant by awatermolecule.
A more severe effect was observed with mutations of Tyr-182.
The alanine substitution of Tyr-182 (Y182A) impeded the
RhaPS backbone biosynthesis significantly, whereas Y182F
completely inactivated GacB (Fig. S6, lanes 9 and 10), suggest-
ing an essential role for the Tyr-182 hydroxyl group in GacB’s
enzymatic activity.
We further investigated themutants D160N and Y182F in an
in vitro assay using recombinantly expressed and purified
GacB-GFP fusions (Fig. S3). The MALDI-MS analysis of the
reaction products from GacB-D160N-GFP and GacB-Y182F-
GFP revealed that bothmutants lacked an enzymatic activity in
vitro (Fig. 3,G andH). These results support the hypothesis that
the residues Asp-160 and Tyr-182 play a role in substrate bind-
ing or catalysis.
Finally, we created three truncated versions of GacB at the
N-terminal end as an attempt to determine whether the
enzyme remains active in the absence of the residues pre-
dicted to be associated with the membrane. Our results
showed that truncations of the first 22 (GacB23–385), 75
(GacB76–385), and 118 residues (GacB119–385) led to inacti-
vation of the enzyme when assessed through the comple-
mentation assay (Fig. S6, lanes 11–13). Their inability to
complement gacB suggest that the N-terminal domain is
required for activity and supports the hypothesis that GacB
is a membrane-associated rhamnosyltransferase.
GacB is a retaining-1,4-rhamnosyltransferase
The current gene annotation suggests that GacB is an invert-
ing -1,2-rhamnosyltransferase (7, 14). This annotation is
incompatible with the acceptor sugar GlcNAc because its car-
bon at positionC2 is already decoratedwith theN-acetyl group.
Therefore, GacB can only transfer the rhamnose onto the avail-
able hydroxyl groups on C3, C4, or C6. The GAC backbone is
composed of disaccharide repeating units of rhamnose con-
nected via -1,3--1,2 glycosidic bonds (15, 18, 85), suggesting
that GacB could be using a retaining mechanism of action, syn-
thesizing an-1,3,-1,4, or-1,6 glycosidic linkage. According
to the CAZy database, the GacB sequence is classified as a GT4
family member, which are classified as retaining GTs (73). If
that classification is correct for GacB, the stereochemical con-
figuration at the anomeric center of the sugar donor, TDP--L-
rhamnose, should be retained in the final product (56, 64, 74).
To elucidate whether GacB is an inverting or a retaining
rhamnosyltransferase, we conducted NMR spectroscopy on
the purified reaction products 1 and 2. 1H NMR spectra were
collected at 800 MHz to both establish the structural integrity
of acceptors 1 and 2 (Fig. 4A) and determine the chemical struc-
ture of their products after the enzymatic reaction (products 1
and 2). The NMR parameters were determined through one-
and two-dimensional (1D and 2D) and 2D total correlation
spectroscopy (TOCSY) experiments (Fig. 4B); their chemical
shifts are summarized in Table 2. For both acceptors, the ano-
meric proton of the -D-GlcNAc residue appeared as a doublet
of doublets with 3J(H1,H2)  3.4 Hz and 3J(H1,P)  7.2 Hz.
Proton H2 of -D-GlcNAc was also split by a 3J(H2,P) 2.4 Hz
coupling with P. A 2D 1H, 31P HMQC spectrum (data not
shown) revealed a correlation of both of these H-1 protons
with P at 13.5 ppm. Another correlation appeared between
the 31P at10.6 ppmandprotons of the adjacentCH2 groups of
the alkyl chain, confirming the integrity of the acceptor sub-
strate. For acceptor 2, a typical pattern of signals of monosub-
stituted benzene with integral intensities of 2:2:1 was observed.
The addition of rhamnose to both acceptor substrates was
accompanied by the appearance of a characteristic signal in the
anomeric region of the spectrum (4.88 ppm, H1) next to the
water signal. The anomeric configuration of this monosaccha-
ride was established in several ways. The measured 3J(H1,H2)
coupling constant of 1.0 Hz indicated a -L-configuration (1.1
and 1.8 Hz reported) (75) for -L- and -L-Rha, respectively).
Furthermore, we complemented our studies by investigating
the product rotating-frame NOE (ROESY) spectrum (Fig. 4B).
Importantly, the ROESY spectrum showed spatial proximity of
H1 of rhamnose with four other protons. Among these were
H2, H3, andH5 protons of rhamnose, the latter two confirming
a 1,3-diaxial arrangement betweenH1,H3, andH5 that is indic-
ative of a -L-Rha configuration. Finally, a comparison of 1H
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Figure 4. A, 800-MHz 1H NMR spectra of acceptor substrate 1 (a), product 1 (b), acceptor substrate 2 (c), and product 2 (d). B, partial 2D ROESY spectrum of
product 1 showing the correlations between the H1 of-L-Rha and the protons of rhamnose (R) and protons of GlcNAc (G). The F2 cross-section throughH1 of
Rha is shown in red. C, chemical structures with proton numbering.
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chemical shifts of rhamnose with those of -L- and -L-rham-
nopyranose (Fig. 4C) showed a good agreement with those of
-L-rhamnose but not -L-rhamnose (75) (Table 2), thus fur-
ther confirming the anomeric configuration of this ring. The
forth ROESY cross-peak of H1 of rhamnose was with H4 of
GlcNAc, revealing the presence of a (134) linkage between the
two monosaccharides. This observation was further supported
by a comparison of GlcNAc 1H chemical shifts of acceptor sub-
strates and products. Here, an increased chemical shift (0.21
ppm) was observed for H4 upon glycosylation, whereas the
average of the absolute values of the differences between the
chemical shifts of the other corresponding protons of GlcNAc
was 0.03 ppm. As expected, the signals of the alkyl and aryl
radicals practically did not change in the respective acceptor-
product pairs.
In conclusion, 1HNMR spectroscopy revealed the formation
of a -L-Rha (134) D-GlcNAc moiety and the integrity of the
product. Other enzymes from Gram-negative and Gram-posi-
tive bacteria that are involved in polysaccharide biosynthesis
also use lipid-linked GlcNAc as the initial acceptor sugar,
whereas their nucleotide-sugar donor is either TDP-L- or GDP-
D-rhamnose. However, their respective reaction products are
-1,3 or -1,4 glycosidic bonds (76–81). Product analysis,
therefore, undoubtedly reveals that GacB is the first retaining
GT that synthesizes a novel D-GlcNAc--1,4-L-rhamnose
disaccharide using TDP--L-rhamnose as the exclusive nucle-
otide sugar donor.
Group A, B, C, and G Streptococcus share a common RhaPS
initiation step
In addition to S. mutans SccB, GacB homologs with a high
degree of sequence identity are found in other streptococcal
species of clinical importance, such as the Streptococcus species
from Group B (GBS), Group C (GCS), and Group G (GGS). All
homologous enzymes are situated in the corresponding gene
clusters encoding the biosynthesis of their Lancefield antigens
Table 2
1H chemical shifts (ppm) of acceptor substrates and products 1 and 2
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(i.e. theGroup B, C, andG carbohydrate) (15). The homologous
gene products share 67, 89, and 89% amino acid identity to
GacB, respectively (Table 1 and Fig. 5).With varying degrees of
evidence, depending on the species, there is a general under-
standing of the chemical structure of the RhaPS of these strep-
tococci (15). The currently accepted structures for GAC, GBC,
GCC, GGC, and SCC are summarized in Fig. 5 (14–16, 23, 82,
83). Remarkably, none of the investigations that led to the
understanding of the surface carbohydrate structures include
data describing the mechanism of action of the enzymes in-
volved in the priming step of each RhaPS biosynthesis.
Based on the high-sequence identity to GacB, we hypoth-
esized that the carbohydrate biosynthesis of the Group A,
Group B, Group C, and Group G Streptococcus possesses a
conserved initiation step, in which the first rhamnose resi-
due is transferred onto the lipid-linked acceptor forming
-D-GlcNAc--1,4-L-rhamnose-PP-Und. We tested the
ability of the homologs from GBS, GCS, and GGS (GbsB,
GcsB, and GgsB, respectively) to functionally substitute
GacB in the production of the RhaPS chain (Fig. 6). Our
results show that all homologous proteins were able to
restore the RhaPS backbone when their genes were co-ex-
pressed with the gacB expression plasmid, suggesting that
these enzymes can perform the same enzymatic reaction.
We showed that GacB requires GlcNAc-PP-Und as acceptor
(Fig. 6), but it is possible that the enzymes fromGBS, GCS, and
GGS use a different lipid-linked acceptor substrate, such as
Glc-PP-Und. Thus, to determine whether the GacB homologs
require GlcNAc-PP-Und as lipid acceptor, we conducted the
complementation assay using E. coli wecA cells, which lack
GlcNAc-PP-Und (62). As a positive control, we identified
Streptococcus pneumoniae WchF, a -D-Glc--1,4-L-rhamno-
syltransferase that uses Glc-PP-Und exclusively as substrate
(84). As expected, GacB was unable to restore the RhaPS chain
when co-transformed with the gacB vector in the absence of
the GlcNAc-PP-Und (Fig. 6A, lane 2). Importantly, the GacB
homologs from GBS, GCS, and GGS also failed to produce the
RhaPS backbone (Fig. 6A, lanes 4–6) but could replace GacB
function in the rfaS strain (Fig. 6B). OnlyWchF, which uses a
Glc-PP-Und acceptor for the transfer of a rhamnose residue
(83), restored the RhaPS biosynthesis in the absence of
GlcNAc-PP-Und (Fig. 6A, lane 3). Combined with the data
Figure 5. Schematic representation of the RhaPS initiation within different Streptococcus species compared with the capsule polysaccharide in
S. pneumoniae. RhaPS biosynthesis is initiated on Und-P by GacO (green background), followed by the action of GacB (turquoise), generating the conserved
core structureUnd-PP-GlcNAc-Rha. Percentage of the amino acid sequence identity, positive amino acids, and gapswithin the sequence comparedwithGacO
or GacB are given below each homolog: S. mutans Xc serotype C SccB, S. agalactiae (GBS) RfaB, Streptococcus dysgalactiae subsp. equisimilis 167 (GCS) RgpAc,
and S. dysgalactiae subsp. equisimilis ATCC 12394 (GGS) Rs03945. The specific carbohydrate composition extending the lipid-linked core structure of each
group is depicted on the right. Carbohydrate repeat units (RU) are highlighted (light pink background), and symbolic representations of the sugars are shown in
the key.
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from our in vitro enzymatic reactions, these results strongly
suggest that the GacB homologs from GBS, GCS, and GGS
are also -D-GlcNAc--1,4-L-rhamnosyltransferase that
require GlcNAc-PP-Und as membrane-bound acceptor.
D-GlcNAc- or D-Glc-1,4--L-rhamnosyl-transferases define
translocationmechanism in streptococcal pathogens
S. pneumoniae serotype 2 wchF encodes a -D-Glc--1,4-L-
rhamnosyltransferase that requires Glc-PP-Und as acceptor
(84). The WchF enzyme conducts the first committed step for
Wzx/Wzy-dependent capsule biosynthesis. Interestingly, it
shares only 51% amino acid identity to GacB, compared with
67–89% for the homologous enzymes from GBS, GCS, GGS,
and S. mutans (Table 1). Toward a better understanding of the
conservation of GacB in the Streptococcus genus, we extended
our bioinformatics analysis to search for other strains that har-
bor gacB homologous genes. We found 48 human/veterinary
pathogenic Streptococcus species with a single GacB homolog,
sharing 50–94% amino acid sequence identity (Table 1 and Fig.
7). Interestingly, only five of our 48 identified species showed a
percentage identity equal to or lower than 51% (Streptococcus
mitis, S. pneumoniae, Streptococcus oralis subsp. tigurinus,
S. peroris, and Streptococcus pseudopneumoniae), whereas all
other encoded proteins presented more than 65% homology to
GacB. For simplicity, we will refer to the five Streptococcus strains
with low amino acid identity as the “low-identity” subgroup, and
the rest of the species as the “high-identity” subgroup. The
sequence analysis paired with the complementation assay led
us to hypothesize that all GacB homologs encompassed in the
high-identity subgroup possess D-GlcNAc--1,4-L-rhamnosyl-
transferase activity. In contrast, the low-identity subgroup con-
tains S. pneumoniae WchF, a known D-Glc--1,4-L-rhamnosyl-
transferase (84). Interestingly, all fivemembers of the low-identity
subgroup exhibit very high sequence identity (90%) when com-
pared with WchF, therefore strongly suggesting that they are
WchF homologs that also synthesize Rha--1,4-Glc-PP-Und.
GacO from S. pyogenes, theWecAhomolog, was shown to be
responsible for the biosynthesis of the GlcNAc-PP-Und (14,
15), the substrate for GacB.We therefore hypothesized that the
low- and high-identity subgroups utilize different substrates
and therefore investigated whether a similar discrepancy
should be observed when comparing the sequence identity of
theGacOhomologs. Strikingly, within the 48 pathogenic strep-
tococci genomes (Table 1 and Fig. S7), we found that all strains
from the high-identity subgroup share a GacO homolog with
63–92% sequence identity. Importantly, any genome from the
low-identity subgroup contains a gene product with 30%
sequence identity to GacO. This subgroup contains gene prod-
ucts that have high homology to S. pneumoniae Cps2E, which
transfers Glc-1-P to P-Und, to generate Glc-PP-Und (51, 84).
S. mitis, S. oralis subsp. tigurinus, S. peroris, and S. pseudopneu-
moniae homologs share 98% sequence identity to Cps2E. Thus,
we propose that their capsule polysaccharides are also built on
Glc-PP-Und.
The degree of phylogenetic conservation of GacB in the
Streptococcus genus highlights the importance of this gene, and
perhaps of the entire RhaPS gene cluster, for survival and
pathogenesis of streptococcal pathogens. Overall, these results
lead us to propose that those streptococcal species that have
GacB homologs with a high degree of identity (65%) are
D-GlcNAc--1,4-L- rhamnosyltransferases that catalyze the
first committed step in the biosynthesis of their surface RhaPS
by transferring rhamnose from TDP--L-rhamnose to the
Figure 6. Bacterial complementation assay in E. coli 21548 (A) and E. coli CS2775 (B). Shown is immunoblotting of Tricine SDS-PAGE with whole-cell
samples probed with anti-Group A carbohydrate antibody and membranes after Coomassie stain.
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membrane-bound GlcNAc-PP-Und. In contrast, we postulate
that the species encompassed in the low-identity subgroup, fol-
lowing the function of S. pneumoniae serotype 2WchF, contain
a rhamnosyltransferase that acts on lipid-linked Glc-PP-Und.
It is worth noticing that the capsule biosynthesis in S. pneu-
moniae and other Gram-positive bacteria occurs via the Wzx/
Wzy-dependent pathway, and the polymerization of the glycan
occurs after the export of the repeating unit by Wzy (84–86).
Importantly, 75% of all S. pneumoniae capsular polysaccha-
rides are synthesized onto the reducing end of lipid-linked Glc,
and strikingly, the elongation of the repeat unit occurs on that
very same glucose (87, 88). This information strongly suggests
that a reducing end GlcNAc is not compatible with the elonga-
tion step via the polymerase Wzy. The Wzx translocation
mechanism is commonly used for the synthesis of several sur-
face carbohydrates of lactic acid bacteria, as well as for the pro-
duction of the lipopolysaccharide and capsules in Gram-nega-
tive species (78–80). In contrast, the elongation step of the
GAC biosynthesis pathway is proposed to take place in the
cytoplasm before the translocation via the hypothesized ABC
transporter. The species encompassed within the low-identity
subgroup all containWzx/Wzy genes downstreamof theWchF
homolog, whereas the high-identity subgroups share the same
type of ABC transport genes with their respective surface
RhaPS gene clusters (Table 1).
GacB’s N-terminal domain encodes specificity for the GlcNAc
acceptor
We decided to further investigate the role of the N- and
C-terminal domains in acceptor substrate recognition. GTs
showahighdegree of specificity toward both the sugar acceptor
and the nucleotide-activated sugar donor (89). Although the
majority of GTs possess either a GT-A or GT-B type structure
fold, the direct function of the GTs cannot be predicted, as they
do not tend to share conserved residues associated with the
enzymatic activity or have a commonmechanism of action (64,
89). Nevertheless, it has been observed that the N-terminal
domain of GT-B folded GTs is responsible for the acceptor
substrate recognition, whereas the C-terminal domain is
involved in sugar–nucleotide donor binding (90). Despite the
poor sequence identity to known GT4 protein sequences, we
trusted our bioinformatic analysis indicating that GacB has
structural similarity to theGT4 family, a group of retainingGTs
that have aGT-B fold.Wehave revealed thatGacB is a retaining
GT, and our sequence analysis revealed that the protein has two
distinct domains. We investigated whether this observation
correlates to a lower sequence percentage identity in the N-ter-
minal domain than in the C-terminal domain when compared
with WchF. If this were the case, then these differences should
also extend to the other species encompassed in the high-iden-
tity subgroup.
We performedmultiple-sequence alignment of theGacB ho-
mologs from all 48 streptococcal pathogens to identify themost
variable and conserved regions in the protein sequence. We
observed a higher discrepancy between the high-identity and
the low-identity subgroups in their N-terminal domains (Table
1 and Fig. S7). More precisely, a low sequence conservation
region is identifiable between the GacB amino acid residues 40
and 80, suggesting that this section of the domain is either
Figure 7. A, phylogenetic tree of GacB homolog sequences identified from 48 partially or completely sequenced streptococcal pathogens. The tree was
constructed based onmultiple-sequence alignment of GacB homologs using the default neighbor-joining clusteringmethod of Clustal Omega. The tree was
plotted using iTOL online tool. Black squares at the branches indicate species with fully sequenced genomes. B, bar charts associated with each node indicate
the amino acid identity (percentage) of the respective homologs to GacO (magenta) or GacB (blue) from S. pyogenes.
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involved in the GlcNAc acceptor sugar recognition or essential
protein–protein interactions.
We knew from our previous experiment that GacB could not
initiate the RhaPS biosynthesis on a wecA deletion background
(Fig. 6A, lane 2). Based on this information and to identify res-
idues involved in sugar acceptor recognition, we introduced
mutations in the GacB amino acid sequence. The goal was to
salvage the RhaPS initiation step in a wecA-deficient E. coli
strain in which GacB mutants recognize a lipid-linked sugar
acceptor other than GlcNAc-PP-Und. E. coli contains the wcaJ
gene that encodes the enzyme that synthesizes Glc-PP-Und.
Therefore, we investigated a structural model based on the
GacB homolog from Bacillus anthracis, BaBshA (PDB entry
3MBO), which suggested that residues Leu-128 and Arg-131
and Gly-100, Asn-101, Thr-102 (GNT100) may potentially be
involved in sugar acceptor recognition. We mutated these res-
idues to mimic those found inWchF. Complementation assays
using GacB L128H_R131L failed to complement gacB in a
wecA background (Fig. 8, lane 2). Following a sequential
approach, we modified GacB primary sequence by introduc-
ing additional amino acid substitutions that corresponded to
those found in WchF: L128H_R131L_GNT100ARC and
L128H_R131L_GNT100ARC_A105P.None of thesemutant pro-
teinswere able to initiate the rhamnose chainonUnd-PP-Glc and,
thus, did not restore GacB’s activity. Finally, we replaced the first
178 residues of GacB with the corresponding WchF amino acids
(residues 1–186).Whenexpressed in awecAdeletionbackground,
this WchF-GacB chimera was able to synthesize the RhaPS
backbone on the exclusive acceptor substrate Glc-PP-Und (Fig. 8,
lane 5).
In light of our findings, we postulate that the C-terminal
domain of GacB is involved in the GT reaction, whereas the
N-terminal domain, which includes the uncharacterized
DUF1972 domain, participates in lipid-linked substrate recog-
nition and binding. A distinction in domain functionality has
been suggested for other GTs of the GT4 family. For instance,
inMshA, a GT4 in C. glutamicum, the donor substrate binding
occurs at the C-terminal domain through the residues located
at the 12/10 loop, whereas the N-terminal domain is involved
in acceptor binding (57). Likewise, biochemical and structural
studies onWsaF, a rhamnosyltransferase involved in elongating
the polysaccharide’s backbone chain in the Gram-positive bac-
terium Geobacillus stearothermophilus NRS 2004/3a, indicate
that the acceptor-binding region is located at the N-terminal
domain, whereas the C-terminal domain is associated with
sugar donor transfer (85, 86). Interestingly, WsaF’s C-terminal
end is involved in TDP-Rha binding and contains an EX7E
motif, also found among its homologs and other putative rham-
nosyltransferases. Remarkably, all GacB streptococcal homo-
logs contain a similar GX7E motif that may be involved in the
GT activity. This sequence contains neither the proline-rich
motif nor a conserved tyrosine (Tyr-329) that is suggested to be
involved in the rhamnose binding described for WsaF (85)
(Fig. 8).
Furthermore, GacB-related homologs have a fully conserved
GGTNPGLLE sequence, whereas the S. pneumoniae WchF-
like subgroup has a GGTNPSLLE sequence, suggesting that yet
another mechanism may be used to bind and select for TDP-
Rha in streptococcal Lancefield species. In terms of the mech-
anismof action, kinetic and structural data collected fromother
retaining rhamnosyltransferases of the GT-B family suggest
that the stereochemical outcome is a result of a double-dis-
placementmechanism facilitated by interdomain flexibility (66,
72, 76, 78, 87–90). However, further biochemical and structural
work is required to pinpoint the catalytic residues in GacB and
its homologs.
Altogether, these results, although insufficient to pinpoint
the individual residues that recognize the lipid sugar acceptor,
demonstrate that GacB belongs to the GT-B superfamily and
has a high substrate selectivity toward theGlcNAc acceptor and
Figure 8. Bacterial complementation assay in E. coli 21548 cells, lacking the genewecA and subsequently lacking GlcNAc-PP-Und as an acceptor for
lipid-linked carbohydrate biosynthesis. A, immunoblot of whole-cell samples probed with anti-Group A carbohydrate antibody and Coomassie staining
(right) (B).
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TDP--L-rhamnose as the nucleotide sugar donor. Impor-
tantly, our data strongly suggest that the acceptor recognition
takes places at the N-terminal domain, opening the possibility
of assigning a role in acceptor binding to the domain of
unknown function DUF1972 as the GlcNAc-PP–binding site.
Conclusions
In recent years, the biosynthesis of GAC, a major structural
component of the cell wall in S. pyogenes (14, 15), has received
increased attention. Thework of van der Beek et al. in 2015 (24)
shed light on the role of GacA in the production of the nucleo-
tide sugar TDP--L-rhamnose, which is used to build the GAC
backbone chain (7). Collectively, the research of Rush et al.(14)
andEdgar et al. (18) revealed the role ofGacHIJKL, the enzymes
involved in chain modification after the translocation step.
Despite this progress, the production of the RhaPS backbone,
which involves the initiation and elongation stages of the GAC
biosynthesis, remained unexplored. Our work unveils the func-
tion of GacB, the first GT of this pathway, which conducts a
conserved priming step in the RhaPS biosynthesis.
Several research groups have shown that studying the GAC
cluster directly in S. pyogenes, including the generation of con-
ditional knockouts, constitutes a real technical challenge (7,
24). The genes encoding GacB, as well as GacA, GacC–G, and
GacL, were indispensable for S. pyogenes survival in transposon
mutagenesis experiments (7, 10, 25).
It remains unknownwhether the GAC is essential for Group A
Streptococcus survival or if the lethal phenotype observed after
deletion of genes of the gene cluster is a result of the accumulation
of GlcNAc-PP-Und, GlcNAc-P-Und, or any other intermediate
LLS. For instance, the accumulation of the lipid-linked precursor
has been observed after the deletion of gacABC, gacG, and gacL
homologous genes involved in S. pneumoniae serotype 2 capsule
biosynthesis and in Bacillus subtilis and Staphylococcus aureus
wall teichoic acid biosynthesis (22, 73, 84). Importantly, until
today, no gene has been identified in Streptococcus species that
couldconvert/recycle these lipid-linked intermediates, ashasbeen
described for other bacteria (99).
In B. subtilis and S. aureus, secondary deletions of the early-
acting gene, such as the one involved in GlcNAc-PP-Und
biosynthesis, tagO/tarO (73), reverse the lethal phenotype
observed as a consequence of interrupting the polymerization
of these secondary cell wall structures. Under those circum-
stances, the genes involved in wall teichoic acid polymerization
are no longer essential, albeit their deletion leads to cells with
compromised fitness, and this phenomenon could also be the
case for the GAC biosynthesis pathway. Importantly, disrup-
tion of the gacO gene has been shown to cause cell death (25).
However, van Sorge et al. (7) showed that low concentrations of
tunicamycin (0.025%), a specific inhibitor of undecaprenyl-
phosphate GlcNAc-1-phosphate transferase (WecA/GacO)
producing GlcNAc-PP-Und, lead to viable S. pyogenes cells
with no RhaPS in their cell walls (25). Therefore, it would be
interesting to investigate whether the gac gene deletions men-
tioned earlier cause the same lethal phenotype in tunicamycin-
treated S. pyogenes strains.
We have demonstrated that GacB is a functional homolog of
SccB, the proposed first rhamnosyltransferase in the RhaPS
synthesis pathway of S. mutans serotype c (26). Previous
research on S. mutans and in silico studies of theGroupB Strep-
tococcus polysaccharide biosynthesis clusters showed that
GacB homologs are likely to be rhamnosyltransferases, but no
biochemical evidence was ever provided to support these
hypotheses (26, 82, 91). Here, we provide the first biochemical
confirmation that GacB is a -1,4-L-rhamnosyltransferase, in
opposition to its preliminary annotation (7, 14, 15). We also
reveal that GacB does not require divalent cations for its activ-
ity, which is consistent with the absence of a DXD motif in its
primary sequence (70, 89) (Fig. S5).
The combined results presented here encourage GacB’s
inclusion in the GT4 subfamily, although the enzymes of this
CAZy family are currently limited to those who utilize -config-
ured nucleotide sugars. Furthermore, the data presented in this
work support the hypothesis that the N-terminal domain is
responsible for the binding of the lipid-linked substrate as well as
the association to the bacterialmembrane in the cytosol.We spec-
ulate that the domain of unknown function DUF1972 is fulfilling
this role.
We observed thatmutations in the highly conserved residues
Asp-160 andTyr-182 abrogatedGacB’s priming activity in both
the in vivo complementation and the in vitro enzymatic activity
assays (Fig. 3 and Fig. S6). In the absence of a crystal structure or
one from closely related homologs, we can only speculate on
the role of these residues based on the existing literature of
other GT-B retaining GT. Tyrosine residues have been de-
scribed in the literature as essential active-site residues for the
catalytic activity of several glycosyltransferases. Their proposed
roles are diverse and range fromacting as a catalytic base, where
the Tyr side chain can activate the acceptor hydroxyl group
(92), to constituting nucleotide sugar ribose-binding residues
(93). In this context, we hypothesize that the hydroxyl group of
Tyr-182 might fulfill one of the two proposed roles in the GAC
initiation process. In the absence of a crystal structure, or a
suitable homologous structure, we cannot reveal themechanis-
tic details of GacB and the role of this conserved Tyr-182.
Another exciting outcome of this research has been the find-
ing that the reaction catalyzed by GacB, the formation of
Rha--1,4-GlcNAc-PP-Und, is highly conserved in the Strepto-
coccus genus. The bacterial complementation assays and the
bioinformatics analysis lead us to hypothesize that this initia-
tion step is shared by all streptococcal pathogens expressing a
RhaPS surface carbohydrate (Table 1 and Figs. 6 and 7), includ-
ing but not limited to species from the Lancefield Groups A, B,
C, D, E, F, G, H, K, L, M, N, O, P, and R.
Overall, this work unveils the function of GacB, the first met-
al-independent, retaining, and nonprocessive -D-GlcNAc-
-1,4-L-rhamnosyltransferase reported, and sheds light on the
first committed step of the RhaPS biosynthesis in Group B,
Group C, and Group G Streptococcus.
Importantly, GacB’s essentiality and the lethal phenotype
of GAC-depleted strains, in addition to the high-sequence con-
servation observed for GacB homologs from several strepto-
coccal pathogens, may have significant implications for the
future development of multitarget drugs in polypharmacology,
because humans lack both TDP-Rha and related glycosyltrans-
ferases. Finally, our insights regarding the ability to synthesize
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streptococcal RhaPS in a recombinant expression system,
namely E. coli, onto different lipid-linked acceptor sugars by
substituting the enzyme GacB (or its homologs) provide excit-
ing newopportunities for glycoconjugate vaccine development.
Experimental procedures
Bioinformatics analysis
Alignments of protein sequences were performed using
NCBI Blast Global align (https://blast.ncbi.nlm.nih.gov/
Blast.cgi) and ClustalOmega (https://www.ebi.ac.uk/Tools/
msa/clustalo/)5 (94). Molecular weight predictions were
obtained using the ProtParam tool at the Expasy server (http://
www.expasy.org/) (101).5 Protein topological predictions were
generated using both SpOctopus (http://octopus.cbr.su.se/)5
(102) and the TMHMM algorithms (www.cbs.dtu.dk/services/
TMHMM/).5
Secondary structure predictions were generated using
either Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.
cgi?idindex)5 (103) or RaptorX (raptorx.uchicago.edu)5 and
visualized using PyMOL (educational version 1.8, Schro¨dinger,
LLC). The Carbohydrate-Active enZymes database (CAZy)
(http://www.cazy.org/)5 (73) was examined to obtain informa-
tion about the classification and characterization of carbohy-
drate active enzymes. Phylogeny relationships were established
using Clustal Omega, Clustal X, and iTOL (95).
Bacterial strains and growth conditions
All bacterial strainsused in this study are listed inTable 3.E. coli
strains DH5 and MC1061 were used indistinctively as host
strains for the propagation of recombinant plasmids and plasmid
integration. E. coli CS2775, a strain sourced from Prof. Rodney
Welsh that lacks the Rha modification on the lipopolysaccharide,
was used as the host strain to evaluate the production of RhaPS.
E. coli 21548 is aUnd-PP-GlcNAc–deficient strain that contains a
wecA deletion, serving as a negative control for the production of
RhaPS. The strainwas sourced fromDr. Jeffrey Rush.E. coli strain
C43 (DE3) was used for the production of recombinant protein.
AllE. coli strainswere grown in lysogeny brothmedia.Unless oth-
erwise indicated, all bacterial cultures were incubated at 37 °C in a
shaking incubator at 200 rpm.Where necessary, media were sup-
plementedwith one ormore antibiotics to the following final con-
centration: carbenicillin (Amp) at 100g/l, erythromycin (Erm)
at 300g/l or kanamycin (Kan) at 50g/ml.
Molecular genetic techniques
Table S1 shows the DNA sequence of the forward and
reverse oligonucleotide primer pairs used to amplify, delete, or
5 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
Table 3
Plasmid IDs, genes, primers, and vector details
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mutagenize the genes of interest. All primers were obtained
from Integrated DNA Technologies. All PCRs were performed
using a SimpliAmpThermal Cycler fromThermo Fisher Scien-
tific with standard procedures. Constructs were cloned using
standard molecular biology procedures, including restriction
enzyme digest and ligation. All constructs were validated with
DNA sequencing.
Determination of RhaPS production
Aliquots of 50 l of A600-normalized overnight cultures
grown at 37 °Cweremixedwith 50l of 6	 SDS-loading buffer
and resolved in 20% Tricine-SDS gels (96). Assessment of the
RhaPS production was performed via immunoblotting on polyvi-
nylidenedifluoridemembranes following the traditional immuno-
blotting technique. Primary antibody was rabbit-raised anti-
S. pyogenes Group A carbohydrate polyclonal antibody (Abcam,
ab21034). Secondary antibody was goat-raised anti-rabbit IgG
horseradish peroxidase conjugate (Bio-Rad, 170-6515). Immuno-
reactive signals were captured using either GENESYSTM 10SUV-
visible spectrophotometer (Thermo Scientific) after exposure to
the ClarityWestern ECL (Bio-Rad).
Extraction and radiolabeling of lipid-linked oligosaccharides
Radiolabeled LLSs of inducedE. coliCS2775 cells bearing the
selected plasmids were extracted using CHCl3/CH3OH and
water-saturated butan-1-ol (1:1 v/v) solution to determine the
addition of sugar residues in vivo after glucose D[6s3H] (N)
(PerkinElmer Life Sciences) supplementation (1 mCi/ml). The
incorporated radioactivity was measured in a Beckman
LS6000SE scintillation counter. The organic phase containing
the LLSs was normalized to 0.05 Ci/l. The samples were
separated via TLC on an HPTLC Silica Gel 60 plate (Merck)
using a C:M:AC:A:W mobile phase (180 ml of chloroform 
140ml of methanol 9ml of 1 M ammonium acetate 9ml of
13M ammonia solution, 23ml of distilledwater), the plateswere
dried and sprayed with En3Hance liquid (PerkinElmer Life Sci-
ences). Radioautography images were obtained using Car-
estream Kodak BioMax XAR Film and MS intensifying
screens after 5–10 days.
Purification of recombinantly expressedmembrane-
associated proteins
The purification was conducted following the established
protocol from Waldo et al. (97) with the following modifica-
tions. Overnight cultures of E. coli C43 (DE3) cells expressing
C-terminal GFP fusion proteins were diluted 1:100, incubated
for 3 h until A600 0.6, induced with 0.5 mM isopropyl 1-thio-
-D-galactopyranoside, and shifted to room temperature over-
night, all at 200 rpm shaking. GFP expression was detected
through in-gel fluorescence using a Fuji FLA-5000 laser scan-
ner. For cloning, expression, and purification of GacB-WT,
GacB-D160N-GFP, and GacB-Y182-GFP, plasmids containing
GFP-His8-tagged recombinant proteins were constructed as
described in Table 3 into the vector pWaldo-E (97). For protein
production and purification purposes, the vectors were trans-
formed into E. coli C43 (DE3) cells and expressed as described
above. The cells were fractionated using an Avestin C3 high-
pressure homogenizer (Biopharma) and spun down at 4000	 g.
Further centrifugation of the supernatant at 200,000 	 g for
2 h rendered 2–3 g of membrane containing the GacB-GFP
proteins. Membranes were solubilized in Buffer 1 (500 mM
NaCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, pH 7.4,
20 mM imidazole, 0.44 mM tris(2-carboxyethyl)phosphine)
with the addition of 1% DDM (Anatrace) for 2 h at 4 °C and
bound to a 1-ml nickel-Sepharose 6 Fast Flow (GE Healthcare)
column, prewashed with buffer 1 plus 0.03% DDM. Elution was
conducted using Buffer 1 supplemented with 250 mM imidazole
and 0.03% DDM. Imidazole was removed using a HiPrep 26/10
desalting column (GE Healthcare) equilibrated with buffer (PBS,
0.03% DDM, 0.4 mM tris(2-carboxyethyl)phosphine). The GFP-
His tagwas removedwith PreScission Protease cleavage in a 1:100
ratio overnight at 4 °C. CleavedGacBproteinswere collected after
negative IMAC. Protein identity and purity was determined by
tryptic peptide mass fingerprinting, matrix-assisted laser desorp-
tion/ionization TOFMS (MALDI-TOF), respectively (University
of Dundee “Fingerprints” proteomics facility).
Synthesis of acceptor 1 and 2
Acceptor 2 (P1-(11-phenoxyundecyl)-P2-(2-acetamido-2-de-
oxy--D-glucopyranosyl) diphosphate, PhO(CH2)11-PP-GlcNAc)
was synthesized as sodium salt from phenoxyundecyl dihydrogen
phosphate and 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl--D-glu-
copyranosyl dihydrogen phosphate according to the procedure
by Druzhinina et al. (98). Acceptor 1 (P1-tridecyl-P2-(2-acet-
amido-2-deoxy--D-glucopyranosyl) diphosphate, CH3(CH2)12-
PP-GlcNAc)was synthesized from tridecyl dihydrogenphosphate
(obtained similarly to phenoxyundecyl dihydrogen phosphate) by
the same procedure as described for acceptor 2.
GacB in vitro enzymatic reaction
Purified GacB-WT-GFP, GacB-D160N-GFP, GacB-Y182F-
GFP, and the GacB (tagless) protein (0.15 mg/ml final con-
centration) were mixed in a 100-l TBS buffer supplemented
with 1 mM TDP-Rha as sugar donor and 1 mM acceptor 1
(CH3(CH2)12-PP-GlcNAc) or 1 mM acceptor 2 (PhO(CH2)11-
PP-GlcNAc)) as acceptor substrate. The reaction was incu-
bated for 3–24 h at 30 °C. The assay mixture was adjusted with
the exchange of the nucleotide sugar donor to UDP-Rha or
UDP-GlcNAc and with the addition of either 1 mM MgCl2, 1
mM MnCl2, or 1 mM EDTA to define the essentiality of metal
dependence.
MS analysis
MALDI-TOF was used to analyze the acceptors and prod-
ucts of the GacB in vitro assay. 100-l reaction samples were
purified over 100-l Sep-Pak C18 cartridges (Waters), pre-
equilibrated with 5% EtOH. The bound samples were washed
with 800 l of H2O and 800 l of 15% EtOH, eluted in two
fractions with (a) 800 l of 30% EtOH and (b) 800 l of 60%
EtOH. The two elution fractions were dried in a SpeedVac and
resuspended in 20 l of 50% MeOH. 1 l of sample was mixed
with 1 l of 2,5-dihydroxybenzoic acid matrix (15 mg/ml in
30:70 acetonitrile, 0.1%TFA), and 1l was added to theMALDI
grid. Samples were analyzed by MALDI in an Autoflex speed
mass spectrometer set up in reflection positive ion mode
(Bruker, Germany).
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NMR analysis
The purified GacB in vitro assay products (0.5–2 mg) were
dissolved in D2O (550 l) and measured at 300 K. The spectra
were acquired on a four-channel Avance III 800-MHz Bruker
NMR spectrometer equipped with a 5-mm TCI CryoProbeTM
with automated matching and tuning. 1D spectra were ac-
quired using the relaxation and acquisition times of 5 and 1.8 s,
respectively. Between 32 and 512 scans were acquired using the
spectral width of 11 ppm. J connectivities were established in a
series of 1D and 2D TOCSY experiments with mixing times
between 20 and 120ms. Selective 1D TOCSY spectra (99) were
acquired using 40-ms Gaussian pulses and DIPSI-2 sequence
(100) (B1/2  10 kHz) for spin lock of between 20 and 120
ms. The following parameters were used to acquire 2D TOCSY
and ROESY experiments: 2048 and 768 complex points in t2
and t1, respectively, spectral widths of 11 and 8 ppm in F2 and
F1, yielding t2 and t1 acquisition times of 116 and 60ms, respec-
tively. 16 scans were acquired for each t1 increment using a
relaxation time of 1.5 s. The overall acquisition time was 6–7
h/experiment. A forward linear prediction to 4096 points was
applied in F1. A zero filling to 4096 was applied in F2. A cosine
square window function was used for apodization prior to Fou-
rier transformation in both dimensions. The ROESY mixing
time was applied in the form of a 250-ms rectangular pulse at
B1/2 4167 Hz. DIPSI-2 sequence (B1/2 10 kHz) was
applied for a 20, 80, and 120 ms spin lock. 2D magnitute mode
heteronuclearmultiple-bond correlation (HMBC) experiments
were conducted using the following parameters: 2048 and 128
complex points in t2 and t1, respectively, spectral widths of 6
and 500 ppm in F2 and F1, yielding t2 and t1 acquisition times of
0.35 s and 0.6 ms, respectively. Two scans were acquired for
each of 128 t1 increments using a relaxation time of 1.2 s. The
overall acquisition time was 8 min. A forward linear prediction
to 512 points was applied in F1; zero filling to 4096 was applied
in F2. A sine square window function was used for apodization
prior to Fourier transformation in both dimensions.
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